Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels

Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels

Item

http://www.wikidata.org/entity/Q35169112

Q35169112

about

In vitro study of the variable effects of proton pump inhibitors on voriconazole The influence of combination use of CYP450 inducers on the pharmacokinetics of voriconazole: a systematic review.Adverse drug reactions due to drug-drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method.Pharmacogenetics may influence the impact of inflammation on voriconazole trough concentrations.Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT.Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.Adverse Drug Reactions in Patients Receiving Systemic Antifungal Therapy at a High-Complexity Hospital.Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections.Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers.Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy.Subtherapeutic voriconazole concentrations associated with concomitant dexamethasone: case report and review of the literature.Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients.Serum C-reactive protein levels affect the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.Effects of cytochrome P450 3A4 and non-genetic factors on initial voriconazole serum trough concentrations in hematological patients with different cytochrome P450 2C19 genotypes.Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped.Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole

P2860

Q35960842-6DB52FC7-540B-4989-9DC5-7854021740D1 Q36273788-DE3B8390-52F8-44DF-AEC1-EBC69A0D5E2E Q38658675-037861B5-457D-4A58-8529-6E84D1471F88 Q38660640-D6348CF8-11BE-405A-8A07-EEF6D5F4E283 Q38690098-229261E0-0B8C-4E53-95A7-B26123840D89 Q38880522-1CB0545E-51AE-4F60-B623-B34B3E3AEA3A Q39479653-8BF5FD2E-93C1-408C-8B90-566D33224057 Q39751871-A319CF26-7AF6-467E-907D-D6C83489A5D8 Q40290020-3C667FEB-87A9-4AC7-A72D-4FAFFB591027 Q40317932-204356B0-5960-4750-9B2D-947DA0458D98 Q40407579-0739595D-3449-44FF-9D5D-6DD67A6D22B1 Q48721069-181603D1-1244-4112-AD4A-5132A2F181EA Q49385523-77E0C2B2-5FB3-4D62-AE47-64355C2B9390 Q50035124-285045EB-24ED-4DB9-A5CC-1353FD932640 Q51095374-0B779F5E-6456-4CCD-8E91-946823A687FD Q51275882-A4573935-AAF5-49FD-8378-3D1C95552420 Q54062385-FA9C1409-A20B-4510-BDA1-25804515BECE Q57162735-5151FC52-4C86-4A81-96E1-688A58ADF575

P2860

Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels

Item

http://www.wikidata.org/entity/Q35169112

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu